• Home
  • Tags: Anti-Doping

U.S. Triathlon Athlete Noah Webb Accepts Sanction for Anti-Doping Rule Violation

USADA Logo

USADA announced today that Noah Webb, of Los Angeles, Calif., an athlete in the sport of triathlon, has accepted a four-year period of ineligibility for an anti-doping rule violation.

Webb, 48, tested positive an anabolic agent as the result of an in-competition urine sample collected at the Toyota USA Triathlon Age Group Olympic National Championships on August 7, 2021. His urine sample was analyzed using a specialized test known as Isotope Ratio Mass Spectrometry (IRMS), which is capable of measuring the carbon isotope ratio of urinary steroids and confirming their synthetic origin—in this case, testosterone or its precursors. IRMS is a powerful tool that unequivocally differentiates between anabolic androgenic steroids (AAS) naturally produced by the body and AAS of synthetic origin. Anabolic agents like testosterone have powerful performance-enhancing capabilities and can give an athlete an unfair advantage over fellow competitors.

WADA publishes IOC Anti-Doping Rules for Beijing 2022 Winter Olympics

Sport Resolutions Logo

The World Anti-Doping Agency (WADA) has published the IOC Anti-Doping Rules applicable to the Beijing 2022 Winter Olympics.

A WADA statement said “The IOC, as the World Anti-Doping Code (Code) Signatory responsible for establishing the Rules applicable to the Games, has established and adopted these Rules to be in line with the 2021 Code and International Standards; most notably, the 2022 List of Prohibited Substances and Methods, which was published on 30 September 2021 and comes into force ahead of the Games on 1 January 2022. The Rules will cover the period from the opening of the Olympic Village on 27 January until the day of the closing ceremony on 20 February 2022.”

WADA co-edits book on emerging drugs in sport

WADA Logo

The World Anti-Doping Agency (WADA) is proud to announce the publication today of a new book, Emerging Drugs in Sport, that was co-edited by WADA’s Senior Director of Science and Medicine, Dr. Olivier Rabin.

The book is the first of its kind on the use of Novel Psychoactive Substances (NPS)* in sports and features contributions by multidisciplinary leading experts in the field. Co-edited in collaboration with Professor Ornella Corazza, Associate Professor in Substance Addiction and Behaviours at the University of Hertfordshire in the United Kingdom and a leading scholar in the field of Novel Psychoactive Substances, the book provides the latest findings on anti-doping including anti-doping techniques, regulation, policy and market structure of NPS used in sports.

WADA extends analytical testing restriction imposed on the Bucharest Laboratory

WADA Logo

The World Anti-Doping Agency (WADA) has extended the analytical testing restriction (ATR) imposed on the Romanian Doping Control Laboratory in Bucharest (Bucharest Laboratory). The ATR, related to the Gas Chromatography / Combustion / Isotope Ratio Mass Spectrometry (GC/C/IRMS) analytical method, was originally imposed in 1 May 2021 for a period of up to six months.

Sport Integrity Australia: weightlifter receives sanction

Sport Integrity Australia Logo

Sport Integrity Australia acknowledges the decision of the Australian Weightlifting Federation to sanction athlete Nathan Mortensen for the presence of prohibited substances and their metabolites and the use and possession of prohibited substances.

Mr Mortensen returned an Adverse Analytical Finding (AAF) from an out-of-competition doping control test on 10 September 2020.

Iranian athlete Nikoeimajd Mehran suspended four years for anti-doping rule violation

IPC Logo

The International Paralympic Committee (IPC) has suspended Iranian Para athletics athlete Nikoeimajd Mehran for a period of four years for committing an anti-doping rule violation (ADRV). 

The athlete was found to have committed an ADRV pursuant to IPC Anti-Doping Code Article 2.2 of the IF Rules: Use or Attempted Use by an Athlete of a Prohibited Substance or a Prohibited Method.

WADA Strategic Testing Expert Advisory Group explores alternative sample collection programs

WADA Logo

From 27-29 September 2021, the World Anti-Doping Agency’s (WADA’s) Strategic Testing Expert Advisory Group held three virtual meetings focused on the following topics:

  • An overview of new and existing areas of testing, including the implementation of Dried Blood Spot (DBS) and sample collection best practices for transgender athletes;
  • A review and update of the ‘Guidance for Testing during COVID-19 Pandemic’ document which was issued in November 2020;
  • A review of the implementation of, and compliance with, the Technical Document for Sports Specific Analysis (TDSSA), including the implementation of the haematological module of the Athlete Biological Passport (ABP); and
  • The progress of a feasibility study on alternative sample collection programs.

WADA invites stakeholders to the eighth International Conference on Novel Psychoactive Substances

WADA Logo

The World Anti-Doping Agency (WADA) is pleased to invite stakeholders to the eighth International Conference on Novel Psychoactive Substances (NPS). The event, which will take place virtually from 17-19 November 2021, is jointly organized by WADA, the United Nations Office on Drugs and Crime (UNODC), the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), the International Society for the Study of Emerging Drugs (ISSED), the University of Hertfordshire, and the Centre for Forensic Science Research and Education (CFSRE).

WADA Foundation Board unanimously approves further governance reforms

WADA Logo
  • Approval of Independent Ethics Board; additional seats on Executive Committee for an athlete representative and an independent member, and on Foundation Board for athletes and National Anti-Doping Organizations; and establishment of WADA Athletes’ Council
  • Athletes’ Anti-Doping Ombuds Program to be piloted next year
  • New Confidential Sources’ Policy approved

UKAD announce Jane Rumble as new Chief Executive

UKAD Logo
  • Jane Rumble joins UKAD from Ofcom where she is the Change Director
  • Starts role in March 2022
  • UKAD Chair Trevor Pearce ‘delighted’ with appointment and highlights Jane Rumble’s extensive regulatory experience

IWGA entrusts ITA with the independent anti-doping program for The World Games 2022 in Birmingham, Alabama

ITA Logo

The International Testing Agency (ITA) is set to manage yet another independent and expert-led anti-doping program for a major event, after completing its missions for the Olympic Games in Tokyo in 2020 and the upcoming Olympic Winter Games in Beijing in 2022. The International World Games Association (IWGA) has entered a collaboration with the ITA for its next major event, The World Games 2022, to be held in July in Birmingham, Alabama (USA).

WADA announces Independent Observer teams for Beijing Olympic and Paralympic Games

WADA Logo

The World Anti-Doping Agency (WADA) is pleased to announce its Independent Observer (IO) program teams for the Winter Olympic and Paralympic Games in Beijing, China, which will take place from 4-20 February and from 4-13 March 2022, respectively.  

WADA’s IO program, which has been running since the 2000 Olympic Games in Sydney, Australia, and has included more than 50 major events during that time, is an important element of WADA’s compliance monitoring of Major Event Organizations. The IO teams provide an independent review of all aspects of the anti-doping programs as delivered at major events, including the Olympic and Paralympic Games.

Powerlifting Athlete Suspended for the Presence and Use of Tamoxifen

CCES Logo

The Canadian Centre for Ethics in Sport (CCES) announced today that Phillipe Marcil, a powerlifting athlete, received a two-year sanction for an anti-doping rule violation. The athlete’s urine sample, collected during in-competition doping control on August 21, 2021, revealed the presence of tamoxifen, a prohibited hormone and metabolic modulator.

WADA publishes updated Therapeutic Use Exemption Physician Guidelines and Checklists reflecting changes concerning injectable glucocorticoids

WADA Logo

The World Anti-Doping Agency (WADA) is pleased to publish the following updated Therapeutic Use Exemption (TUE) Physician Guidelines and Checklists, which reflect the latest rule changes regarding injectable routes of administration of glucocorticoids (GCs) coming into force on 1 January 2022 under the 2022 List of Prohibited Substances and Methods (List).


Copyright © LawInSport Limited 2010 - 2022. These pages contain general information only. Nothing in these pages constitutes legal advice. You should consult a suitably qualified lawyer on any specific legal problem or matter. The information provided here was accurate as of the day it was posted; however, the law may have changed since that date. This information is not intended to be, and should not be used as, a substitute for taking legal advice in any specific situation. LawInSport is not responsible for any actions taken or not taken on the basis of this information. Please refer to the full terms and conditions on our website.